Literature DB >> 2866290

Acute encephalopathy coincident with seroconversion for anti-HTLV-III.

C A Carne, R S Tedder, A Smith, S Sutherland, S G Elkington, H M Daly, F E Preston, J Craske.   

Abstract

Acute encephalopathy was associated with the appearance of antibodies to human T-lymphotropic virus (HTLV-III) in two patients. A third patient showed seroconversion for anti-HTLV-III, but the temporal association was not established so precisely. The illness was characterised by a prodromal period of up to 2 weeks, characterised by pyrexia, general malaise, and changes of mood. The encephalopathy culminated in epileptiform seizures in two of the patients. Electroencephalographic changes were compatible with viral encephalitis, and cerebrospinal-fluid pleocytosis was minimal. Neurological signs and symptoms resolved quickly in all patients, and no residual central-nervous-system sequelae were apparent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866290     DOI: 10.1016/s0140-6736(85)90740-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

1.  Acute meningoencephalitis and meningitis due to primary HIV infection.

Authors:  P J Newton; W Newsholme; N S Brink; H Manji; I G Williams; R F Miller
Journal:  BMJ       Date:  2002-11-23

2.  Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients.

Authors:  L Hagberg; A Forsman; G Norkrans; E Rybo; L Svennerholm
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 3.  Clinical, virological and immunological features of primary HIV-1 infection.

Authors:  M D de Jong; H J Hulsebosch; J M Lange
Journal:  Genitourin Med       Date:  1991-10

4.  Acute ataxia coincident with seroconversion for anti-HIV.

Authors:  E Scarpini; G Sacilotto; A Lazzarin; L Geremia; R Doronzo; G Scarlato
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

5.  Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia.

Authors:  J T Shieh; A V Albright; M Sharron; S Gartner; J Strizki; R W Doms; F González-Scarano
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Subacute encephalopathy associated with human immunodeficiency virus in haemophilia A.

Authors:  A Rahemtulla; S T Durrant; J M Hows
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-18

7.  Neurological manifestations of human immunodeficiency virus infection.

Authors:  C A Carne; M W Adler
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

8.  Severe illness associated with appearance of antibody to human immunodeficiency virus in an African.

Authors:  R J Biggar; B K Johnson; S S Musoke; J B Masembe; D M Silverstein; M M Warshow; S Alexander
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

9.  Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV.

Authors:  R Kaiser; R Dörries; W Lüer; S Poser; H D Pohle; K Felgenhauer; V ter Meulen
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

10.  Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study.

Authors:  M J Harrison; S P Newman; M A Hall-Craggs; C J Fowler; R Miller; B E Kendall; M Paley; I Wilkinson; B Sweeney; S Lunn; S Carter; I Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.